Barely Significant
← all excerpts

Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.

Osteoporos Int · 2017 · PMC5357292 · PMID 27900428

1
hedged sentence
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.